Senior Analytical Consultant Remote SEC-HPLC Phase3 SME

Senior Analytical Consultant Remote SEC-HPLC Phase3 SME

Full-Time 60000 - 84000 Β£ / year (est.) Working from home possible
P

At a Glance

  • Tasks: Design and manage analytical strategies for innovative enzyme programmes.
  • Company: ProPharma Group, a leader in pharmaceutical consulting.
  • Benefits: Remote work, flexible hours, and the chance to shape industry standards.
  • Other info: Exciting opportunity to work on unlicensed medicines in a dynamic environment.
  • Why this job: Join a cutting-edge project and make a significant impact in drug development.
  • Qualifications: 10-15 years of experience, PhD or MSc in a scientific field, and FDA knowledge.

The predicted salary is between 60000 - 84000 Β£ per year.

Pro Pharma Group is seeking a Principal/Senior Analytical Consultant to design and manage the analytical strategy for a pegylated enzyme program.

The role focuses on SME guidance, Phase 3 method development, and risk mitigation within a remote, 6-month project.

Ideal candidates have 10-15 years in the industry, a Ph D or MSc in a scientific field, and proven experience with unlicensed medicines and FDA registration processes.

Fluent English is required.

Senior Analytical Consultant Remote SEC-HPLC Phase3 SME employer: ProPharma Group

ProPharma Group is an exceptional employer located in Greater London, offering a part-time Senior Clinical Research Associate role that promotes a healthy work-life balance. With a strong commitment to diversity, equity, and inclusion, the company cultivates a supportive work culture where employees are encouraged to grow professionally through continuous learning opportunities. Joining ProPharma means being part of a dynamic team dedicated to advancing clinical research while enjoying the unique advantages of working in one of the UK's most vibrant cities.

P

Contact Details:

ProPharma Group Recruitment Team

We think you need these skills to ace Senior Analytical Consultant Remote SEC-HPLC Phase3 SME

Analytical Strategy Design
Phase 3 Method Development
Risk Mitigation
SME Guidance
Experience with Unlicensed Medicines
FDA Registration Processes
PhD or MSc in a Scientific Field